Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ciclopirox topical - Ortho Dermatologics

Next Previous
Drug Profile

Ciclopirox topical - Ortho Dermatologics

Alternative Names: 12% Ciclopirox lacquer - Ortho Dermatologics; 8% Ciclopirox lacquer - Ortho Dermatologics; Ciclopirox nail lacquer - Ortho Dermatologics; DL 6045; Penlac; Penlac Nail Lacquer

Latest Information Update: 02 Aug 2017

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Dermik Laboratories
  • Developer Ortho Dermatologics
  • Class Antifungals; Proteins; Pyridones; Small molecules
  • Mechanism of Action Mitosis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Onychomycosis

Most Recent Events

  • 27 Jul 2017 Valeant Pharmaceuticals International acquired Ortho Dermatologics in 2011 and changed the name of the later to Valeant Dermatology. Subsequently, in July 2017, it was rebranded to Ortho Dermatologics
  • 16 Dec 2011 Dermik Laboratories has been acquired by Valeant Pharmaceuticals International
  • 27 Aug 2004 Aventis has merged with Sanofi-Synthélabo to form sanofi-aventis

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top